Valuation : Becton, Dickinson and Company

Market Cap 50.97B 43.96B 41.36B 37.71B 70.83B 4,839B 71.33B 490B 190B 2,460B 191B 187B 8,164B P/E 2026 *
36.1x
P/E 2027 * 20.1x
Enterprise Value 66.85B 57.67B 54.25B 49.46B 92.9B 6,347B 93.55B 643B 250B 3,227B 251B 246B 10,708B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.29x
Free-Float
73.18%
Yield 2026 *
2.1%
Yield 2027 * 2.13%
1 day+0.43%
Current month-20.81%
Current year-20.81%
1 year 152.52
Extreme 152.52
192.59
3 years 152.52
Extreme 152.52
192.59
5 years 152.52
Extreme 152.52
253.98
10 years 152.52
Extreme 152.52
260
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+2.57% - - 51.24B
-1.30%-6.63%-17.89%+5.86% 191B
+1.53%-0.93%-0.83%+12.93% 116B
+2.28%+2.22%+13.50%+88.07% 61.75B
-0.53%-1.90%-3.04%-33.04% 51.24B
+1.18%-0.02%+29.30%+54.07% 51.51B
-1.01%-1.01%+19.64%-10.73% 34.36B
+0.23%+1.18% - - 30.73B
-0.72%-4.15%+37.13%-16.77% 24.01B
+1.13%-1.96%-4.47%+15.32% 23.23B
Average +0.32%-1.41%+9.17%+14.46% 64.87B
Weighted average by Cap. +0.17%-1.93%+0.25%+15.79%

Financials

2026 *2027 *
Net sales 19.29B 16.64B 15.66B 14.27B 26.81B 1,832B 27B 185B 72.04B 931B 72.43B 70.85B 3,090B 19.73B 17.02B 16.01B 14.6B 27.42B 1,873B 27.61B 190B 73.69B 952B 74.09B 72.47B 3,161B
Net income 1.44B 1.24B 1.17B 1.06B 2B 136B 2.01B 13.81B 5.36B 69.34B 5.39B 5.28B 230B 2.34B 2.02B 1.9B 1.73B 3.25B 222B 3.27B 22.49B 8.74B 113B 8.78B 8.59B 375B
Net Debt 15.88B 13.7B 12.89B 11.75B 22.07B 1,508B 22.23B 153B 59.32B 767B 59.64B 58.34B 2,544B 13.95B 12.03B 11.32B 10.32B 19.39B 1,325B 19.52B 134B 52.1B 673B 52.38B 51.24B 2,235B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
26/08/26 CHF 152.52 +0.43%
25/08/26 CHF 151.86 -0.65%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
188.11USD
Average target price
195.67USD
Spread / Average Target
+4.02%

Quarterly revenue - Rate of surprise